Clinical Trial Update: Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fluconazole versus micafungin for candidemia in non-neutropenic patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Sepsis

Drugs mentioned

• Diflucan (Fluconazole)
• Mycamine (Micafungin)

Snippet

Sponsor: Kyoto University | Conditions: Candidiasis, Sepsis | Phase 4 | Status: WITHDRAWN